Institutional investors purchased a net $1.7 million shares of VCEL during the quarter ended December 2014 and now own 56.47% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STONEPINE CAPITAL MANAGEMENT LLC Sold 89.1 Thousand shares of Vericel Corp